ROG CH0012032048

Report

Delayed Swiss Exchange - 12/03 11:30:38 am
362.25	CHF		-0.33%

12/03	PAUL BULCKE : Roche says Nestle Chairman Bulcke to leave its board of directors	RE
12/03	Roche to Name New Member to Board of Directors, Re-Elect Chairman	DJ
12/03	ROCHE : Änderungen im Verwaltungsrat von Roche	PU

Summary

Quotes 5-day view Delayed Quote.

Delayed Swiss Exchange

11/29/2021	11/30/2021	12/01/2021	12/02/2021	12/03/2021	Date
357.5(c)	359.65(c)	365.8(c)	363.45(c)	362.25(c)	Last
875 393	2 123 098	1 078 630	1 328 859	1 046 526	Volume
-0.31%	+0.60%	+1.71%	-0.64%	-0.33%	Change

More quotes

Estimated financial data (e)

Sales 2021	62 134 M 67 688 M 67 688 M
Net income 2021	15 273 M 16 638 M 16 638 M
Net cash position 2021	4 368 M 4 759 M 4 759 M
P/E ratio 2021	19,7x
Yield 2021	2,57%

Sales 2022	62 457 M 68 041 M 68 041 M
Net income 2022	15 677 M 17 078 M 17 078 M
Net cash position 2022	9 835 M 10 714 M 10 714 M
P/E ratio 2022	18,8x
Yield 2022	2,67%

Capitalization	314 B 341 B 342 B
EV / Sales 2021	4,98x
EV / Sales 2022	4,87x
Nbr of Employees	101 465
Free-Float	83,5%

More Financials

Company

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The...

Sector

Pharmaceuticals

Calendar

12/09

Presentation

More about the company

Ratings of Roche Holding AG

Trading Rating :

Investor Rating :

ESG Refinitiv :

B+

More Ratings

All news about ROCHE HOLDING AG

12/03	PAUL BULCKE : Roche says Nestle Chairman Bulcke to leave its board of directors	RE
12/03	Roche to Name New Member to Board of Directors, Re-Elect Chairman	DJ
12/03	ROCHE : Änderungen im Verwaltungsrat von Roche	PU
12/03	Changes in the Board of Directors	AQ
12/03	Roche Holding Ltd Announces Paul Bulcke Will Not to Stand for Re-Election to Its Board ..	CI
12/03	REMINDER : Invitation to Roche's virtual analyst event during ESMO IO	PU
12/03	Roche develops new research test kits for Omicron variant	RE
12/03	Roche Unveils Three Testing Kits to Identify Omicron Variant Mutations	MT
12/03	Roche develops new test kits for COVID-19 Omicron variant	RE
12/03	Roche has rapidly developed additional testing options to differentiate mutations in th..	AQ
12/03	Roche Rapidly Developed Additional Testing Options to Differentiate Mutations in the Om..	CI
12/02	Chugai Launches a New Educational Website 'So-Zo LABO' Aiming for a Society that Embrac..	AQ
12/02	ROCHE HOLDINGS AG : UBS sticks Neutral	MD
12/01	Jazz Pharmaceuticals Announces First Patient Enrolled in IMforte Phase 3 Trial Evaluati..	AQ
12/01	AlphaValue/Baader Europe Lowers Price Target on Roche, Maintains Add Recommendation	MT

More news

News in other languages on ROCHE HOLDING AG

12/03	Paul Bulcke tritt nicht mehr als Roche-Verwaltungsrat an
12/03	ROCHE : le conseil d'administration va évoluer
12/03	PAUL BULCKE : Paul Bulcke tritt nicht mehr zur Wiederwahl für Verwaltungsrat an
12/03	Roche prévoit des changements au sein de son conseil d'administration
12/03	ROCHE : la FDA homologue Rituxan pour des traitements oncologiques pédiatriques

More news

Analyst Recommendations on ROCHE HOLDING AG

12/02	ROCHE HOLDINGS AG : UBS sticks Neutral	MD
12/01	AlphaValue/Baader Europe Lowers Price Target on Roche, Maintains Add Recommendation	MT
11/24	ROCHE HOLDINGS AG : UBS sticks Neutral	MD

More recommendations

Provided by Scoopnest.com

Analysis

Roche says Nestle Chairman Bulcke to leave its board of directors